Biblio Discovery — Demo Discovery Service

4 hasil untuk "Boris Decarolis"

Menampilkan 1–4 · 0,32 detik · RSS

  1. Artikel Jurnal

    Differentiated Thyroid Cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment

    Costanza Chiapponi; Milan Janis Michael Hartmann; Boris Decarolis dkk.

    JCRPE, Vol. 15 No. 3 · 2023 · Inggris · DOAJ Scopus

    INTRODUCTION: Differentiated thyroid cancer (DTC) in adolescents rare but with a favorable outcome, despite higher rates of cervical lymph node and pulmonary metastasis compared to adults. The aim of this study was to critically evaluate treatment of adolescents with DTC at a single center…

  2. Artikel Jurnal

    Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature

    Verena Wiegering; Maria Riedmeier; Lester D.R. Thompson dkk.

    Clinical and Translational Radiation Oncology, Vol. 35 · 2022 · Inggris · DOAJ Scopus

    Background and purpose: Pediatric adrenocortical carcinoma (pACC) is a rare disease with poor prognosis. Publications on radiotherapy (RT) are scarce. This review summarizes the current data on RT for pACC and possibly provides first evidence to justify its use in this setting. Materials and…

  3. Artikel Jurnal

    Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation study

    Lieke M. J. van Zogchel; Boris Decarolis; Esther M. van Wezel dkk.

    Journal of Experimental & Clinical Cancer Research, Vol. 43 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Liquid biopsies offer less burdensome sensitive disease monitoring. Bone marrow (BM) metastases, common in various cancers including neuroblastoma, is associated with poor outcomes. In pediatric high-risk neuroblastoma most patients initially respond to treatment, but in the…

  4. Artikel Jurnal

    Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma

    Lisa Werr; Jana Boland; Josephine Petersen dkk.

    The Journal of Clinical Investigation, Vol. 136 No. 7 · 2026 · Inggris · DOAJ Scopus

    Fibroblast growth factor receptor 1 (FGFR1) is recurrently mutated at p.N546 in neuroblastoma. We examined whether mutant FGFR1 is an oncogenic driver, a predictive biomarker, and an actionable vulnerability in this malignancy. FGFR1 mutations at p.N546 were associated with high-risk disease and…